The Modulation of Enzyme Indoleamine 2,3-Dioxygenase From Dendritic Cells for the Treatment of Type 1 Diabetes Mellitus

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s135367
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Indoleamine 2,3-Dioxygenase 1 (IDO1)

Science-Business eXchange
2012English

Transient Upregulation of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Human Chorionic Gonadotropin Downregulates Autoimmune Diabetes

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2007English

Amino Acid Deprivation Links BLIMP-1 to the Immunomodulatory Enzyme Indoleamine 2,3-Dioxygenase

Journal of Immunology
AllergyImmunology
2009English

Inhibition of Indoleamine 2,3-Dioxygenase in Dendritic Cells by Stereoisomers of 1-Methyl-Tryptophan Correlates With Antitumor Responses

Cancer Research
Cancer ResearchOncology
2007English

Indoleamine 2,3-Dioxygenase Is a Signaling Protein in Long-Term Tolerance by Dendritic Cells

Nature Immunology
AllergyImmunology
2011English

Advances in Indoleamine 2,3-Dioxygenase 1 Medicinal Chemistry

MedChemComm
Organic ChemistryMolecular MedicinePharmacologyBiochemistryPharmaceutical ScienceDrug Discovery
2017English

The Silencing of Indoleamine 2,3-Dioxygenase 1 (IDO1) in Dendritic Cells by siRNA-loaded Lipid Nanoparticles Enhances Cell-Based Cancer Immunotherapy

Scientific Reports
Multidisciplinary
2019English

Indole Peroxygenase Activity of Indoleamine 2,3-Dioxygenase

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2012English

The Heme Environment of Recombinant Human Indoleamine 2,3-Dioxygenase

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy